The finding of posterior wall low-voltage zones during cryoballoon ablation for atrial fibrillation predicted a higher risk of atrial arrhythmia recurrence (HR 2.583; 95% CI 1.334-5.002; p = 0.005).
Cohort (n=250)
Does the presence of posterior wall low-voltage zones predict worse clinical outcome in patients undergoing cryoballoon ablation for atrial fibrillation?
The presence of posterior wall low-voltage zones detected by electroanatomical mapping during cryoballoon ablation is a strong predictor of atrial arrhythmia recurrence at 1 year.
Effect estimate: HR 2.583 (95% CI 1.334-5.002)
p-value: p=0.005
Background: The presence of left atrial fibrosis is a marker of advanced remodeling and is associated with a worse outcome after pulmonary vein isolation (PVI). Conventional fluoroscopy-only cryoballoon ablation (CBA) lacks this prognostic information. The addition of electroanatomical mapping (EAM) using the inner lumen spiral catheter allows accurate voltage assessment of the left atrial posterior wall. However, the value of the finding of posterior wall low-voltage zones (pwLVZs) is unknown. Purpose: To study the value of left atrial voltage maps during CBA by comparing clinical and procedural characteristics and clinical outcome between patients with and without pwLVZs. Methods: A cohort of 250 consecutive patients who underwent index CBA for atrial fibrillation was analyzed. All patients underwent pre- and post-procedural EAM using the AchieveTM catheter and EnSiteTM mapping system. The presence of LVZs was evaluated at the postprocedural voltage map of the posterior wall. Clinical success was defined as freedom from documented AF or atrial tachycardia (AT) >30 s after 1 year. Results: PwLVZs were found in 41/250 (16.4%) of patients. Patients with pwLVZs were older (69.3 ± 8.5 vs. 64.2 ± 10.4; p = 0.003), more frequently female (63.4% vs. 32.5%; p < 0.001) and had higher CHA2DS2-VASc scores (3.0 ± 1.6 vs. 2.0 ± 1.5; p < 0.001). The incidence of obesity (31.7% vs. 25.8%; p = 0.048), structural heart disease (35.5% vs. 17.4%; p = 0.021) and persistent AF (68.3% vs. 43.8%; p = 0.004) was higher in the pwLVZs group. Kaplan–Meier analysis of clinical outcome showed a higher recurrence rate in the pwLVZs group. The finding of pwLVZs was a predictor of atrial arrhythmia recurrence during follow-up (HR 2.583; 95%CI: 1.334–5.002; p = 0.005). Conclusions: In CBA facilitated by integrated EAM, pwLVZ was associated with older age, female sex, higher CHADS-VASc scores, obesity, structural heart disease and persistent AF. The finding of pwLVZs is predictive of a worse clinical outcome.
Tijskens et al. (Mon,) conducted a cohort in Atrial fibrillation (n=250). Presence of posterior wall low-voltage zones (pwLVZs) vs. Absence of pwLVZs was evaluated on Atrial arrhythmia recurrence during follow-up (HR 2.583, 95% CI 1.334-5.002, p=0.005). The finding of posterior wall low-voltage zones during cryoballoon ablation for atrial fibrillation predicted a higher risk of atrial arrhythmia recurrence (HR 2.583; 95% CI 1.334-5.002; p = 0.005).